Crohn's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Crohn's Disease, including details on symptoms, diagnosis, treatment, causes, medication.

Volume 1 (2004), Issue 2 (December)

1. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis.
   Am J Gastroenterol, 99(12): 2393-404. [Abstract] [Full-text]
2. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.
   Am J Gastroenterol, 99(12): 2385-92. [Abstract] [Full-text]
3. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
   Am J Gastroenterol, 99(12): 2376-84. [Abstract] [Full-text]
4. Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease.
   Genes Immun, 5(8): 675-7. [Abstract] [Full-text]
5. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis.
   J Leukoc Biol, 76(6): 1111-7. [Abstract] [Full-text]
6. Trichuris suis therapy in Crohn's disease.
   Gut, 54(1): 87-90. [Abstract] [Full-text]
7. CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis.
   Gut, 54(1): 70-7. [Abstract] [Full-text]
8. Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany.
   Int J Colorectal Dis, 20(1): 18-23. [Abstract] [Full-text]
9. Anti-TNF strategies in stenosing and fistulizing Crohn's disease.
   Int J Colorectal Dis, 20(1): 1-8. [Abstract] [Full-text]
10. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Aliment Pharmacol Ther, 20(11): 1347-52. [Abstract] [Full-text]
11. Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study.
    Aliment Pharmacol Ther, 20(11): 1337-46. [Abstract] [Full-text]
12. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study.
    Aliment Pharmacol Ther, 20(11): 1329-36. [Abstract] [Full-text]
13. Oral ulcerations are associated with the loss of response to infliximab in Crohn's disease.
    J Oral Pathol Med, 34(1): 53-5. [Abstract] [Full-text]
14. Liver abscess in inflammatory bowel disease: report of two cases and review of the literature.
    J Gastroenterol Hepatol, 19(12): 1338-42. [Abstract] [Full-text]
15. Laparoscopic surgery in the treatment of Crohn's disease.
    Surg Clin North Am, 85(1): 25-34; vii. [Abstract] [Full-text]
16. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study.
    J Gastroenterol, 39(12): 1158-64. [Abstract] [Full-text]
17. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
    Curr Biol, 14(24): 2217-27. [Abstract] [Full-text]
18. Inflammatory diseases: is ubiquitinated NEMO at the hub?
    Curr Biol, 14(24): R1040-2. [Abstract] [Full-text]
19. Association of TNF-alpha polymorphisms in Crohn disease.
    Hum Immunol, 66(1): 56-9. [Abstract] [Full-text]
20. Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response?
    Lab Invest, 85(1): 137-45. [Abstract] [Full-text]

© 2004-2008 Crohn's Disease Research Today. All Rights Reserved.